CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 03:40PM GMT
Release Date Price: R$34.45 (-1.15%)
Michael Aaron Cherny
BofA Securities, Research Division - Director

Thanks, everyone, for joining us for this session of the BofA Healthcare Conference. Mike Cherny, the health care tech and distribution analyst. It's my pleasure to have with us CVS Health, Shawn Guertin, CFO; and then we have Tom Cowhey, who heads up Capital Markets; Larry McGrath from the IR team in the audience as well.

Questions & Answers

Michael Aaron Cherny
BofA Securities, Research Division - Director

So CVS reported last week. They came with a slide deck, which I think is great. It's going to be a fireside chat. So maybe, Shawn, just to kick things off, you've had these targets out for '24, '25, $9 and $10. Maybe just give a sense of some of the building blocks and where you see like you have the most visibility versus areas that might be more moving pieces, both the upside and downside, given that obviously, a lot of them would be out of your control, too.

Shawn Michael Guertin
CVS Health Corporation - Executive VP & CFO

Yes

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot